The HealthTech Signal
Back to the Top 100

No. 77 Investors

Bill Taranto

President, Merck Global Health Innovation Fund • United States

Pioneer of corporate venture capital in digital health and therapeutics.

Find on LinkedIn
ShareLink copied

The Signal

As a veteran leader of a premier corporate venture fund, his perspectives on digital health validation and enterprise scale guide industry wide standards for strategic partnerships.

Who Bill Taranto is

Pioneer of corporate venture capital in digital health and therapeutics.

As a veteran leader of a premier corporate venture fund, his perspectives on digital health validation and enterprise scale guide industry wide standards for strategic partnerships.

Loading the full dossier

At a glance

Role
President
Organisation
Merck Global Health Innovation Fund
Platforms
LinkedIn, X
Based in
United States, North America
Influence Score 84.8editorial estimate, see how it is built
Reach (25% weight)81

Audience size across LinkedIn, X, YouTube, podcasts and newsletters.

Engagement (20% weight)78

How much the audience actually reacts, comments, shares and subscribes.

Credibility (25% weight)95

Clinical, research, operating or investing track record behind the commentary.

Consistency (15% weight)79

Publishing cadence and how reliably they show up with original work.

Industry impact (15% weight)89

Whether decision makers, policy and capital actually move on what they say.

Scores are subjective editorial estimates compiled by our research desk from public profiles and published work. They are opinion, not measurement, and they are not a judgement of any person's character or ability.

Also in Investors

ShareLink copied

Did we miss something?

Change, add or remove details on this profile. Our desk reviews every request.

This profile is compiled by our research desk from public sources and is published as editorial commentary. Want a correction, an update, or your profile removed? and see our corrections and removals policy.